Fitbit lunches its new platform Fitbit Care
Fitbit has had a tumultuous couple of years, but is beginning to find its feet within the healthcare market against players such as Apple and Jawbone (which has since been liquidated), and undertake a number of mergers and acquisitions to cement its position in the industry.
Recently introducing its platform, Fitbit Care into the market, the business is looking to target employees maintain their health by focusing on health plans and employers which can support employee goals.
Following on from its acquisition of health coaching business, Twine Health, the company has enhanced its wearable health-tracking capabilities by embedding the use of health coaching, which can be adopted in the workplace and help to lower healthcare costs.
- Fitbit and Google partner to drive Innovation in digital health and wearables
- Fitbit diversifies into the glucose tracking market in new investment
- Fitbit partners with DexCom, leading shares to rocket
Accessible through the Fitbit Plus app, users can be enrolled by their employer, health system or plan, and is not yet available for public use. Up to five million Humana members will be able to access the platform, according to Business Insider.
Working in the same manner as before, the technology will effectively combine its health coaching capabilities with self-tracking and virtual care to reach certain goals, such as lowering blood pressure, or supporting those with long-term conditions such as diabetes or hypertension.
However, all data received through the technology will be accessed by healthcare professional who can develop a bespoke package for each user to follow through the coaching application. The coach and associated care team will then provide guidance through phone calls and regular meetings to support users full-time.
The technology will also help users connect with like-minded individuals through the introduction of Fitbit’s social network, where workouts are accessible to support employees further.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”